MarketCap
Facebook
X
TelegramAcceleron Pharma Inc. Total Current Liabilities 2011-2025 | XLRN
Annual Total Current Liabilities Acceleron Pharma Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 60.2 M | 33.4 M | 18.9 M | 16.7 M | 16.1 M | 14.5 M | 9.25 M | 27.2 M | 38.8 M | 23.9 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 60.2 M | 9.25 M | 25.9 M |
Total Current Liabilities of other stocks in the Biotechnology industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aclaris Therapeutics
ACRS
|
31.6 M | $ 3.04 | 0.33 % | $ 235 M |  USA |
 |
Aptevo Therapeutics
APVO
|
6.21 M | $ 0.55 | -10.18 % | $ 152 K | USA |
 |
Autolus Therapeutics plc
AUTL
|
60.7 M | $ 1.8 | 7.9 % | $ 459 M |  Britain |
 |
Alpine Immune Sciences
ALPN
|
58 M | - | - | $ 2.17 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.62 B | - | - | $ 40.3 B | USA |
 |
Aptorum Group Limited
APM
|
4.34 M | $ 1.15 | 1.19 % | $ 6.27 M |  China |
 |
Aeglea BioTherapeutics
AGLE
|
54.1 M | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
3.78 M | - | 1.93 % | $ 17.4 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.77 M | - | -1.52 % | $ 24.7 M | USA |
 |
BioVie
BIVI
|
2.27 M | $ 1.22 | 1.05 % | $ 1.8 M | USA |
 |
AlloVir
ALVR
|
5.24 M | - | 4.14 % | $ 49.1 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
2.38 M | - | -11.43 % | $ 502 K | USA |
 |
Applied Molecular Transport
AMTI
|
15.1 M | - | - | $ 10.1 M | USA |
 |
Avenue Therapeutics
ATXI
|
816 K | - | -52.27 % | $ 4.45 M | USA |
 |
AVROBIO
AVRO
|
6.35 M | - | 1083.1 % | $ 745 M | USA |
 |
BioDelivery Sciences International
BDSI
|
82.4 M | - | -4.8 % | $ 255 M | USA |
 |
Athersys
ATHX
|
29.9 M | - | 3.77 % | $ 22.4 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
556 M | - | - | - |  Russia |
 |
ARCA biopharma
ABIO
|
13 M | - | 1052.0 % | $ 415 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
3.77 M | - | -9.72 % | $ 5.89 M | USA |
 |
Acasti Pharma
ACST
|
1.93 M | - | 4.01 % | $ 150 M |  Canada |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.05 M | $ 0.18 | -14.31 % | $ 392 M |  Israel |
 |
Adaptimmune Therapeutics plc
ADAP
|
72.8 M | - | -15.15 % | $ 60.3 M | Britain |
 |
Berkeley Lights
BLI
|
45.5 M | - | -7.31 % | $ 87 M | USA |
 |
Catalyst Biosciences
CBIO
|
20 M | $ 12.24 | -0.93 % | $ 806 M | USA |
 |
Albireo Pharma
ALBO
|
45.3 M | - | -0.23 % | $ 916 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
174 M | $ 27.02 | -0.37 % | $ 1.31 B | USA |
 |
BeiGene, Ltd.
BGNE
|
2.21 B | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Calithera Biosciences
CALA
|
14 M | - | -10.95 % | $ 876 K | USA |
 |
Certara
CERT
|
146 M | $ 8.83 | -0.67 % | $ 1.42 B | USA |
 |
Anika Therapeutics
ANIK
|
31.1 M | $ 9.57 | 0.21 % | $ 140 M | USA |
 |
bluebird bio
BLUE
|
200 M | - | - | $ 546 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
66.3 M | - | -6.81 % | $ 3.04 B | USA |
 |
Acer Therapeutics
ACER
|
19 M | - | 2.71 % | $ 14 M | USA |
 |
Axon Enterprise
AXON
|
1.68 B | $ 580.12 | -0.64 % | $ 43.9 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
7.54 M | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
63.1 M | $ 2.47 | 0.82 % | $ 15.5 M | USA |
 |
ChromaDex Corporation
CDXC
|
17.9 M | - | -0.88 % | $ 598 M | USA |
 |
Acorda Therapeutics
ACOR
|
228 M | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
1.66 M | - | -5.38 % | $ 6.06 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
141 M | $ 81.86 | -0.96 % | $ 8.45 B | USA |